Market Tracker

07/01 6:01pm ET

Alimera Sciences Inc (NASDAQ:ALIM)

4.63
Delayed Data
As of Jul 01
 +0.02 / +0.43%
Today’s Change
3.98
Today|||52-Week Range
6.54
-16.43%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close4.61
Today’s open4.63
Day’s range4.56 - 4.87
Volume100,797
Average volume (3 months)122,059
Market cap$204.7M
Dividend yield--
Data as of 4:00pm ET, 07/01/2015

Growth & Valuation

Earnings growth (last year)+43.83%
Earnings growth (this year)+17.22%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+349.95%
P/E ratioNM
Price/Sales26.57
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GTXIGTX Inc+0.04+2.72%
SYNSynthetic Biologics ...-0.07-2.46%
STMLStemline Therapeutic...+0.05+0.42%
CYNACynapsus Therapeutic...+0.19+1.17%
Data as of 4:00pm ET, 07/01/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$8.4M
Annual profit (last year)-$36.7M
Net profit margin-435.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles Daniel Myers
Secretary, Chief Operating &
Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts